India’s Mobocertinib EGFR Inhibitor 160mg Capsules

Mobocertinib is an EGFR inhibitor. It’s used to treat non-small cell lung cancer in patients who have a specific kind of mutation in the EGFR gene. How it works is by focusing on the EGFR protein to slow down tumor growth.

It comes as 40 mg capsules. The usual dose is 160 mg per day, taken any time, whether you eat or not. One bottle has 90 capsules, so it’s enough for a 30-day supply with the recommended dose.

Mobocertinib is absorbed throughout the body, but it mainly works at the tumor site. Possible side effects can be skin reactions, tummy troubles, and eye issues, and more. Patients need to be checked often to see if they have any bad reactions.